<VariationArchive VariationID="2017547" VariationName="NM_052989.3(IFT122):c.273-374_273-369dup" VariationType="Duplication" Accession="VCV002017547" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2065188" VariationID="2017547">
      <GeneList>
        <Gene Symbol="IFT122" FullName="intraflagellar transport 122" GeneID="55764" HGNC_ID="HGNC:13556" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q21.3-22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="129440224" stop="129520507" display_start="129440224" display_stop="129520507" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="129158967" stop="129239190" display_start="129158967" display_stop="129239190" Strand="+" />
          </Location>
          <OMIM>606045</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_052989.3(IFT122):c.273-374_273-369dup</Name>
      <CanonicalSPDI>NC_000003.12:129460852:GATCTTG:GATCTTGATCTTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="129460852" stop="129460853" display_start="129460852" display_stop="129460853" variantLength="6" positionVCF="129460852" referenceAlleleVCF="A" alternateAlleleVCF="AGATCTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="129179695" stop="129179696" display_start="129179695" display_stop="129179696" variantLength="6" positionVCF="129179695" referenceAlleleVCF="A" alternateAlleleVCF="AGATCTT" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.129179697_129179702dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.129179697_129179702dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.129460854_129460859dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.129460854_129460859dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023392.1" sequenceAccession="NG_023392" sequenceVersion="1" change="g.25730_25735dup">
            <Expression>NG_023392.1:g.25730_25735dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001280545.2" sequenceAccession="NM_001280545" sequenceVersion="2" change="c.-178-374_-178-369dup">
            <Expression>NM_001280545.2:c.-178-374_-178-369dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_052989.3" sequenceAccession="NM_052989" sequenceVersion="3" change="c.273-374_273-369dup" MANESelect="true">
            <Expression>NM_052989.3:c.273-374_273-369dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018262.4" sequenceAccession="NM_018262" sequenceVersion="4" change="c.273-374_273-369dup">
            <Expression>NM_018262.4:c.273-374_273-369dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001280546.2" sequenceAccession="NM_001280546" sequenceVersion="2" change="c.-178-374_-178-369dup">
            <Expression>NM_001280546.2:c.-178-374_-178-369dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_052990.3" sequenceAccession="NM_052990" sequenceVersion="3" change="c.194-2706_194-2701dup">
            <Expression>NM_052990.3:c.194-2706_194-2701dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_052989.3(IFT122):c.273-374_273-369dup AND Cranioectodermal dysplasia 1" Accession="RCV002856848" Version="2">
        <ClassifiedConditionList TraitSetID="1271">
          <ClassifiedCondition DB="MedGen" ID="C0432235">Cranioectodermal dysplasia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20493458</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23826986</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26792575</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1271" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4868" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEVIN SYNDROME I</ElementValue>
                <XRef Type="MIM" ID="218330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cranioectodermal dysplasia 1</ElementValue>
                <XRef ID="Cranioectodermal+Dysplasia/1962" DB="Genetic Alliance" />
                <XRef ID="MONDO:0021093" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CED1</ElementValue>
                <XRef Type="MIM" ID="218330" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cranioectodermal dysplasia (CED) is a ciliopathy with skeletal involvement (narrow thorax, shortened proximal limbs, syndactyly, polydactyly, brachydactyly), ectodermal features (widely spaced hypoplastic teeth, hypodontia, sparse hair, skin laxity, abnormal nails), joint laxity, growth deficiency, and characteristic facial features (frontal bossing, low-set simple ears, high forehead, telecanthus, epicanthal folds, full cheeks, everted lower lip). Most affected children develop nephronophthisis that often leads to end-stage kidney disease in infancy or childhood, a major cause of morbidity and mortality. Hepatic fibrosis and retinal dystrophy are also observed. Dolichocephaly, often secondary to sagittal craniosynostosis, is a primary manifestation that distinguishes CED from most other ciliopathies. Brain malformations and developmental delay may also occur.</Attribute>
                <XRef ID="NBK154653" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24027799</ID>
                <ID Source="BookShelf">NBK154653</ID>
              </Citation>
              <XRef ID="1515" DB="Orphanet" />
              <XRef ID="C0432235" DB="MedGen" />
              <XRef ID="MONDO:0021093" DB="MONDO" />
              <XRef Type="MIM" ID="218330" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5910921" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17110118|MedGen:C0432235" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003222181" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20493458</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23826986</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26792575</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Trp93*) in the IFT122 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT122 are known to be pathogenic (PMID: 20493458, 23826986, 26792575). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with IFT122-related conditions. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IFT122" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.129179695_129179696insGATCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0432235" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5910921" TraitType="Disease" MappingType="XRef" MappingValue="C0432235" MappingRef="MedGen">
        <MedGen CUI="C0432235" Name="Cranioectodermal dysplasia 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

